Vaccin sanofi france - activities

Covid: Sanofi's vaccine soon to be allowed in Europe

Is the Sanofi vaccine soon to be marketed? This Tuesday July 20, 2021, the European Medicines Agency has announced they are to launch a rolling review of results from phase 3 of the ongoing clinical trial of the French laboratory candidate vaccine in order to allow or not marketing issuance as soon as possible. Issuance could actually occur in the first six months of 2022, although it has been announced for late 2021.

Covid: Sanofi stops trials on their mRNA vaccine

This Tuesday September 28, Sanofi has announced they are halting clinical trials as for Covid mRNA vaccine as developed by American biotech Translate Bio, saying it is too late to reach the market. Yet, the vaccine was promising according to the study's preliminary results.

Covid: take a stock on Sanofi vaccine currently completing clincal trial phase 3

Sanofi France CEO Olivier Bogillot announced this July 5th on France Inter the vaccine developed by the laboratories will be available by December 2021. The vaccine is currently completing phase 3 of their trial.

Covid: Sanofi to help Pfizer producing vaccine in Europe

This Tuesday January 26, in the evening, French laboratory Sanofi announced they will help rival Pfizer producing their vaccine in Europe as they are behind elaborating theirs. All in all, over 100 million doses are to be manufactured in Frankfurt by the end of 2021.